Sustained Viral Suppression After Switch To Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) Among Clinical Trial Participants With Preexisting M184v/IJuergen Rockstroh,Kristen Andreatta,Rima Acosta,Michelle L. D'Antoni,Danielle P. Porter,Silvia Chang,Ross Martin,Madeleine Willkom,Ian Mcnicholl,Joel Gallant,Hiba Graham,Sean Collins,Hal Martin,Kirsten L. WhiteINFECTION(2021)引用 1|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要